Filing Details

Accession Number:
0001179110-16-031625
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-15 17:18:16
Reporting Period:
2016-11-11
Filing Date:
2016-11-15
Accepted Time:
2016-11-15 17:18:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1578845 Allergan Plc AGN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587868 Teresa Maria Hilado Clonshaugh Business And Technology Park,
Coolock, Co.
Dublin L2 D17 E400
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.0001 Acquisiton 2016-11-11 702 $213.31 12,659 No 4 P Direct
Ordinary Shares, Par Value $0.0001 Acquisiton 2016-11-11 720 $208.05 13,379 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $208.00 to 208.06, inclusive. The reporting person undertakes to provide Allergan plc, any security holder of Allergan plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price range set forth in footnote (1) of this Form 4.
  2. Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.